Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia [2]

Journal of Child and Adolescent Psychopharmacology

Volumn 15, Issue 6, 2005, Pages 844-845

  Mane A ^a   Baeza, I ^a   Morer, A ^a   Lazaro M L ^a   Bernardo, M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CLOZAPINE; DIAZEPAM; LEVOMEPROMAZINE; RISPERIDONE;

ADOLESCENT; AGITATION; CASE REPORT; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEVER; HUMAN; LETTER; MALE; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; REMISSION; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; COMBINED MODALITY THERAPY; ELECTROCONVULSIVE THERAPY; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; METHOTRIMEPRAZINE; NEUROLEPTIC MALIGNANT SYNDROME; RECURRENCE; RISPERIDONE; SCHIZOPHRENIA;

EID: 29944445528     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2005.15.844     Document Type: Letter

References (9)

1. Ghaziuddin N, Kutcher SP, Knapp P, and the Work Group on Quality Issues: Summary of the practice parameter for the use of electroconvulsive therapy with adolescents. J Am Acad Child Adolesc Psichiatry 43:123-125, 2004.
2. Hasan S, Buckley P: Novel antipsychotics and the neuroleptic malignant syndrome: A review and critique. Am J Psychiatry 155:1113-1116, 1998.
3. Robb AS, Chang W, Lee HK, Cook MS: Risperidone-induced neuroleptic maligant syndrome in an adolescent. J Child Adolesc Psychopharmacol 10:327-330, 1998.
4. Scheftner WA, Shulman RB: Treatment choice in neuroleptic malignant syndrome. Conv Ther 8:267-279, 1992.
5. Shalev A, Hermesh H, Munitz H: Mortality from neuroleptic malignant syndrome. J Clin Psychiatry 50:18-25, 1989.
6. Sharma R, Trappler B, Ng YK, Leeman CP: Risperidone-induced neuroleptic malignant syndrome. Ann Pharmacother 30:775-778, 1996.
7. Silva RR, Munoz DM, Alpert M, Perlmutter IR, Diaz J: Neuroleptic malignant syndrome in children and adolescents. J Am Acad Child Adolesc Psychiatry 38:187-194, 1999.
8. Trollor JN, Sachdev PS: Electroconvulsive treatment of neuroleptic malignant syndrome: A review and report of cases. Austr N Z J Psychiatry 33:650-659, 1999.
9. Villanueva J, García J, Aida J, Tous N: Síndrome neuroléptico maligno asociado a risperidona en un paciente pediátrico: Anales españoles de pediatria 49:652-653, 1998.